All Curated Mutation Sites in IV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in IV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
HA1
  
HA2
  
M1
  
M2
  
NA
  
NP
  
NS1
  
NS2
  
PA
  
PB1
  
PB2
  

Keyword: HA2
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 23397331 E374K
HA2
HA
Influenza A
G
S
C
L
View
2 23397331 I321V
HA2
HA
Influenza A
G
S
C
L
View
3 32459617 V200I
HA2
HA
Influenza A
G
L
View
4 37436149 E374K
HA2
HA
Influenza A
G
R
S
L
View
5 37436149 E46K
HA2
HA
Influenza A
G
R
S
L
View
6 22328930 E374K
HA2
HA
Influenza A
Influenza B
G
L
View
7 34745027 A530V
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
8 34745027 D160N
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
9 34745027 G150E
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
10 34745027 G155E
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
11 34745027 G479E
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
12 34745027 G484E
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
13 34745027 I140M
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
14 34745027 I406V
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
15 34745027 I478M
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
16 34745027 I77V
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
17 34745027 L516I
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
18 34745027 M346L
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
19 34745027 V200I
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
20 34745027 V529I
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
21 34745027 E179D
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
22 34745027 E374K
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
23 34745027 E499K
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
24 34745027 E506D
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
25 34745027 I404M
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
26 34745027 K504R
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
27 34745027 S451N
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
28 34745027 V520A
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
R
C
L
View
29 34745027 I76M
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
30 34745027 N169S
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
31 34745027 V192A
HA2
HA
Influenza like Illnesses
Severe Acute Respiratory Infections
G
C
L
View
32 3753607 G4E
HA2
HA
Cell line
View
33 39138310 K82E
HA2
HA
Cell line
G
View
34 39138310 R163K
HA2
HA
Cell line
G
View
35 9835519 R124M
HA2
HA
Cell line
D
G
L
View
36 36293269 D457G
HA2
HA
Cell line
G
View
37 24391498 K47E
HA2
HA
Cell line
G
R
View
38 3003392 D132N
HA2
HA
Cell line
View
39 3753607 E11G
HA2
HA
Cell line
View
40 2295311 D112G
HA2
HA

View
41 37235589 W14A
HA2
HA

View
42 30141905 G1E
HA2
HA

View
Contents
Description

The table shows all curated mutation sites of IV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.